T. Jared Bunch,
MD
Languages Spoken: English
Dr. T. Jared Bunch, a native of Logan Utah, graduated from Utah State University with University and Department honors and received the Bill Robbins memorial award for leadership, service, and academics. He then graduated from the University of Utah School of Medicine and received Alpha Omega Alpha honors. He completed his internal medicine residency at Mayo Clinic in Rochester Minnesota. During residency he received the Outstanding Achievement Award from the Department of Medicine, the Resident Research Award from the Department of Medicine, and the Donald J. Feist Primary Care Clinic Award for Clinical Excellence. He completed fellowships in cardiovascular diseases and electrophysiology at the Mayo Clinic in Rochester Minnesota. He received the Mayo Brothers Distinguished Fellowship Award for clinical care of patients and the Donald C. Balfour Award for meritorious research. He served as an Assistant Professor of Medicine at the Mayo Clinic from 2003-2007. After fellowship he joined the cardiovascular team at Intermountain Heart Institute and directed heart rhythm research. He served as the medical director of heart rhythm services for Intermountain Healthcare. At Intermountain Medical Center he received the Physician Researcher of the Year for the Intermountain Healthcare System in 2014 and in 2017. In 2012, he was awarded a Healthcare Hero Award for Innovation by the Utah Business Association. While at Intermountain Healthcare he also was an Affiliated Clinical Associate Professor for Stanford University from 2015-2019. In 2019 he left Intermountain Healthcare to join the faculty at the University of Utah School of Medicine as a Professor of Medicine.
Dr. Bunch is active in the Heart Rhythm Society and has served as an ambassador for Central and South America and Southeast Asia. He is the founding editor of the Heart Rhythm Case Reports Journal. He is a section editor for Current Cardiology Risk Reports, Heart Rhythm Journal, and a guest editor for American Heart Journal. He is on the editorial boards of the Heart Rhythm Journal, Journal of Cardiovascular Electrophysiology, Heart, American Heart Journal, JACC electrophysiology, and the Journal of Innovations in Cardiac Rhythm Management.
Dr. Bunch specializes in the diagnosis and management of heart rhythm disorders. He performs a broad range of procedures including endocardial and epicardial catheter ablation, insertion of implantable loop recorders, pacemakers (leadless and traditional), implantable cardioverter defibrillators (ICDs – subcutaneous and traditional), and biventricular ICDs and pacemakers. He has extensive ablation experience in treatment of abnormal heart rhythms including supraventricular tachycardia, atrial fibrillation, WPW (Wolff-Parkinson-White syndrome), ventricular tachycardia, ventricular fibrillation, and premature ventricular contractions.
Dr. Bunch is interested in the management of atrial and ventricular arrhythmias, in particular nonpharmacologic strategies such as catheter ablation and in enhancing the safety of both pharmacologic and nonpharmacologic treatments. His current research involves defining mechanisms underlying the association of atrial fibrillation and dementia and looking at therapeutic opportunities to lower risk of cognitive decline, the integration of wearable and implantable devices to improve early diagnosis and treatment of arrhythmias, and in improving mapping and catheter ablation of arrhythmias.
As list of his publications can be found at: https://www.ncbi.nlm.nih.gov/pubmed/?term=jared+bunch+or+bunch+tj
Clinical Locations
801-213-3200
Fax: (801) 581-7735
Cardiovascular Center
801-585-7676
Fax: (801) 581-7735
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Professor (Clinical) |
| Academic Divisions | Cardiovascular Medicine |
| Board Certification | American Board of Internal Medicine (Sub: Cardiovascular Disease) American Board of Internal Medicine (Sub: Clinical Cardiac Electrophysiology) National Board of Echocardiography |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
4.9/ 5
Care provider's effort to include me in decisions
4.9/ 5
Wait time at clinic
4.7/ 5
Care provider's concern for questions & worries
4.9/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
March 11, 2022
UH HOSPITALS AND CLINICS
Since I new to the State, Dr. Bunch asked about other doctors I need. He recommended Dr. Cox, as a cardiologist specializing in Marfan Syndrome.
UofU Patient
March 06, 2022
FARMINGTON HEALTH CENTER
Everything went very well. I'm at ease now with the condition of care and not as concerned with the problems have. I thought My heart problem was getting worse, but Dr Bunch explained it is all under control.
UofU Patient
March 06, 2022
UH HOSPITALS AND CLINICS
The technician was very detailed and caring and the preparation to inform Doctor Bunch for better care was excellent as was Doctor Bunch care and recommendations.
UofU Patient
February 28, 2022
FARMINGTON HEALTH CENTER
Dr Bunch is wonderful
UofU Patient
February 22, 2022
UH HOSPITALS AND CLINICS
Dr. Bunch has been incredible. He takes the time to listen to you and wants to know you as a person, not just another patient. He did my ablation in September and it gave me my quality of life back.
UofU Patient
February 03, 2022
UH HOSPITALS AND CLINICS
Dr. Bunch is AMAZING! He diagnosed my heart Issue by examining the results of my 30 day heart monitor. At my appointment, he explained the issue to me in layperson's terms replete with drawing a picture to illustrate what was going on. He offered options for treatment explaining the risks and benefits of each. Then when I chose the treatment option of an ablation, he performed the procedure meticulously the next week. I could not be more Impressed with his expertise, knowledge, charisma, and caring ways. Thank you for hiring physicians of the caliber of Dr.Thomas Bunch at the University of Utah.
UofU Patient
February 01, 2022
FARMINGTON HEALTH CENTER
Without Dr. Bunch's unique and special abilities in cardioelectrophysiology, I would not be alive today. Dr. Bunch is always sincerely interested in my condition and how I am progressing (or having difficulty). He is very clear in his instructions to me. He has a very pleasant bedside manner. I am pleased and privileged to be under his very capable medical care.
UofU Patient
January 31, 2022
FARMINGTON HEALTH CENTER
Appreciate his knowledge and experience. Excellent care
UofU Patient
December 25, 2021
UH HOSPITALS AND CLINICS
Dr. Bunch is kind, knowledgeable and thorough in his explanations. I could couldn't ask for a better cardiologist.
UofU Patient
December 21, 2021
FARMINGTON HEALTH CENTER
Best possible care
UofU Patient
December 21, 2021
UH HOSPITALS AND CLINICS
Of all of the physicians I have worked with on my cardiology health Dr. Bunch took the most time and explained the most clearly my options and risks
UofU Patient
December 20, 2021
FARMINGTON HEALTH CENTER
Dr Bunch is the textbook example of a true professional surgeon.
UofU Patient
December 18, 2021
UH HOSPITALS AND CLINICS
A good listener
UofU Patient
December 13, 2021
UH HOSPITALS AND CLINICS
Dr Bunch is an outstanding heart specialist with extraordinary bedside manners. He treats you like a member of his familyvery caring
UofU Patient
December 11, 2021
UH HOSPITALS AND CLINICS
Dr Bunch has always been a good communicator.
UofU Patient
December 10, 2021
UH HOSPITALS AND CLINICS
Dr Bunch and his entire staff were excellent caregivers. It couldn't have gone better.
UofU Patient
November 19, 2021
UH HOSPITALS AND CLINICS
Good
UofU Patient
November 13, 2021
UH HOSPITALS AND CLINICS
Dr. Binch, his nurse, his P.A. (Will), and his resident were customarily personable, attentive, and knowledgeable.
UofU Patient
November 12, 2021
UH HOSPITALS AND CLINICS
Good experience
UofU Patient
November 05, 2021
UH HOSPITALS AND CLINICS
Excellent discourse about current status and plan of treatment with physician.
UofU Patient
November 02, 2021
UH HOSPITALS AND CLINICS
Skilled surgeon
UofU Patient
October 24, 2021
UH HOSPITALS AND CLINICS
Dr Bunch and those that work with and in conjunction with him are excellent. They are very informative, attentive, knowledgeable and still have time to answer questions and concerns. One of my best experiences at the University hospital.
UofU Patient
October 12, 2021
UH HOSPITALS AND CLINICS
I had a good experience.
UofU Patient
September 04, 2021
UH HOSPITALS AND CLINICS
Dr Bunch is personable, caring, and always makes me feel like I'm his top priority and favorite patient. I never feel rushed and he slows me to share any concerns or changes in how I feel. I feel like he's the best of the best. I feel fortunate that he's my doctor.
UofU Patient
September 01, 2021
FARMINGTON HEALTH CENTER
I greatly appreciated the time Dr. Bunch took to answer my questions and address my concerns. I know he is extremely busy but I didn't ever feel like he was trying to rush to the next patient.
UofU Patient
August 22, 2021
UH HOSPITALS AND CLINICS
Excellent evidence-based AND patient-focused approach to tough treatment options.
UofU Patient
August 08, 2021
UH HOSPITALS AND CLINICS
Love Dr. Bunch. Really a great experience!
UofU Patient
July 21, 2021
UH HOSPITALS AND CLINICS
First half of my visit was with his PA; she was not as informed of my case as Dr Bunch.
UofU Patient
July 19, 2021
UH HOSPITALS AND CLINICS
Dr. Bunch was the first provider that took the time to thoroughly explain my issue, took the time to listen, and then developed a good plan for treatment. He's extremely personable and knowledgeable.
UofU Patient
July 10, 2021
UH HOSPITALS AND CLINICS
My fist interaction with this doctor. Very impressive.
UofU Patient
July 10, 2021
UH HOSPITALS AND CLINICS
THE BEST EXPERIENCE POSSIBLE.
UofU Patient
June 21, 2021
FARMINGTON HEALTH CENTER
great doctor
UofU Patient
June 19, 2021
UH HOSPITALS AND CLINICS
best doctor I've had
UofU Patient
June 18, 2021
UH HOSPITALS AND CLINICS
Really like Dr. Bunch!
UofU Patient
June 18, 2021
FARMINGTON HEALTH CENTER
currently following counsel and directions
UofU Patient
June 15, 2021
FARMINGTON HEALTH CENTER
Doctor very kind and caring and listened to all my stories.
UofU Patient
June 11, 2021
UH HOSPITALS AND CLINICS
Everything went well and organized
UofU Patient
May 28, 2021
UH HOSPITALS AND CLINICS
Dr Bunch took the time to answer all of my questions and he provided clear feedback on the tests that I was given
UofU Patient
May 16, 2021
UH HOSPITALS AND CLINICS
good
UofU Patient
May 15, 2021
UH HOSPITALS AND CLINICS
Dr. Bunch has been fantastic to work with throughout my experience with the medical center. he is sincere, caring and extremely knowledgeable about what is going on. It's great having a provider that explains what is going on and listens to ny concerns and input.
UofU Patient
May 08, 2021
UH HOSPITALS AND CLINICS
good experience
UofU Patient
May 02, 2021
UH HOSPITALS AND CLINICS
Dr Bunch is the kindest, most brilliant doctor I have ever seen.
UofU Patient
May 02, 2021
UH HOSPITALS AND CLINICS
it was a very good experience
UofU Patient
April 30, 2021
UH HOSPITALS AND CLINICS
I'm very happy he's my doctor, the experience couldn't have been better.
UofU Patient
April 30, 2021
UH HOSPITALS AND CLINICS
Dr. Bunch is an excellent doctor. He has taken care of my problems, he or his staff are available at any time to address my concerns, and I feel he is genuinely concerned about solving any issue I bring up.
UofU Patient
April 23, 2021
UH HOSPITALS AND CLINICS
Dr. Bunch listened to and answered all my questions and provided the information I needed to make decisions about my own health care. He's terrific.
UofU Patient
April 20, 2021
UH HOSPITALS AND CLINICS
Appoint.ent was better than I could have imagined. Dr. Bunch listed to my health.concern. He showed interest and concern. He drew a diagram.of my heart and explained the cause of Aifib. He explained why my currens meds were causing problems and what procedures could eliminate or modify them. He ordered the procedures as best options, and then told me I could choose whichever I felt comfortable with. He earned my trust by showing empathy, concern, knowledge, and surgical experience. He is the best heart doctor I have seen over the years.
UofU Patient
April 16, 2021
UH HOSPITALS AND CLINICS
Dr. Bunch use drawings, written explanations, and oral explanations to help me better understand my health concern. I learned a lot in a short time. He took time to clearly explain my options, and ordered them according to priority. He carefully answered my questions. And he has a great sense of humor. I felt at ease in no time. I left the office with a clear understanding of next steps.
UofU Patient
April 10, 2021
UH HOSPITALS AND CLINICS
Dr. Bunch seemed like a very down to earth individual, I can't imagine this guy being unfriendly to anyone.
UofU Patient
April 10, 2021
UH HOSPITALS AND CLINICS
in fact I already have
Dr. T. Jared Bunch, a native of Logan Utah, graduated from Utah State University with University and Department honors and received the Bill Robbins memorial award for leadership, service, and academics. He then graduated from the University of Utah School of Medicine and received Alpha Omega Alpha honors. He completed his internal medicine residency at Mayo Clinic in Rochester Minnesota. During residency he received the Outstanding Achievement Award from the Department of Medicine, the Resident Research Award from the Department of Medicine, and the Donald J. Feist Primary Care Clinic Award for Clinical Excellence. He completed fellowships in cardiovascular diseases and electrophysiology at the Mayo Clinic in Rochester Minnesota. He received the Mayo Brothers Distinguished Fellowship Award for clinical care of patients and the Donald C. Balfour Award for meritorious research. He served as an Assistant Professor of Medicine at the Mayo Clinic from 2003-2007. After fellowship he joined the cardiovascular team at Intermountain Heart Institute and directed heart rhythm research. He served as the medical director of heart rhythm services for Intermountain Healthcare. At Intermountain Medical Center he received the Physician Researcher of the Year for the Intermountain Healthcare System in 2014 and in 2017. In 2012, he was awarded a Healthcare Hero Award for Innovation by the Utah Business Association. While at Intermountain Healthcare he also was an Affiliated Clinical Associate Professor for Stanford University from 2015-2019. In 2019 he left Intermountain Healthcare to join the faculty at the University of Utah School of Medicine as a Professor of Medicine.
Dr. Bunch is active in the Heart Rhythm Society and has served as an ambassador for Central and South America and Southeast Asia. He is the founding editor of the Heart Rhythm Case Reports Journal. He is a section editor for Current Cardiology Risk Reports, Heart Rhythm Journal, and a guest editor for American Heart Journal. He is on the editorial boards of the Heart Rhythm Journal, Journal of Cardiovascular Electrophysiology, Heart, American Heart Journal, JACC electrophysiology, and the Journal of Innovations in Cardiac Rhythm Management.
Dr. Bunch specializes in the diagnosis and management of heart rhythm disorders. He performs a broad range of procedures including endocardial and epicardial catheter ablation, insertion of implantable loop recorders, pacemakers (leadless and traditional), implantable cardioverter defibrillators (ICDs – subcutaneous and traditional), and biventricular ICDs and pacemakers. He has extensive ablation experience in treatment of abnormal heart rhythms including supraventricular tachycardia, atrial fibrillation, WPW (Wolff-Parkinson-White syndrome), ventricular tachycardia, ventricular fibrillation, and premature ventricular contractions.
Dr. Bunch is interested in the management of atrial and ventricular arrhythmias, in particular nonpharmacologic strategies such as catheter ablation and in enhancing the safety of both pharmacologic and nonpharmacologic treatments. His current research involves defining mechanisms underlying the association of atrial fibrillation and dementia and looking at therapeutic opportunities to lower risk of cognitive decline, the integration of wearable and implantable devices to improve early diagnosis and treatment of arrhythmias, and in improving mapping and catheter ablation of arrhythmias.
As list of his publications can be found at: https://www.ncbi.nlm.nih.gov/pubmed/?term=jared+bunch+or+bunch+tj
Academic Locations
School of Medicine
801-585-7676
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Professor (Clinical) |
| Academic Divisions | Cardiovascular Medicine |
| Board Certification | American Board of Internal Medicine (Sub: Cardiovascular Disease) American Board of Internal Medicine (Sub: Clinical Cardiac Electrophysiology) National Board of Echocardiography |
Selected Publications - Journal Articles
Journal Article
- Steinberg BA, Li Z, Shrader P, Chew DS, Bunch TJ, Mark DB, Nabutovsky Y, Shah RU, Greiner MA, Piccini JP (2021). Bimodal distribution of atrial fibrillation burden in 3 distinct cohorts: What is 'paroxysmal' atrial fibrillation? Am Heart J, 244, 149-156.
- Baykaner T, Pundi K, Lin B, Lu Y, DeSutter K, Lhamo K, Garay G, Nunes JC, Morin DP, Sears SF, Chung MK, Paasche-Orlow MK, Sanders LM, Bunch TJ, Hills MT, Mahaffey KW, Stafford RS, Wang PJ (2022). The ENHANCE-AF Clinical Trial to Evaluate an Atrial Fibrillation Shared Decision-Making Pathway: Rationale and Study Design. Am Heart J.
- Chew DS, Li Z, Steinberg BA, OBrien E, Pritchard J, Bunch TJ, Mark DB, Patel MR, Nabutovsky Y, Greiner MA, Piccini JP (2021). Association between Economic and Arrhythmic Burden of Paroxysmal Atrial Fibrillation in Patients with Cardiac Implanted Electronic Devices. Am Heart J, 244, 116-124.
- Anderson JL, Knight S, McCubrey RO, May HT, Mason S, Bunch TJ, Min DB, Cutler MJ, Le VT, Muhlestein JB, Knowlton KU (2021). Absent or Mild Coronary Calcium Predicts Low-Risk Stress Test Results and Outcomes in Patients Considered for Flecainide Therapy. J Cardiovasc Pharmacol Ther, 26(6), 648-655.
- Martinez MW, Kim JH, Shah AB, Phelan D, Emery MS, Wasfy MM, Fernandez AB, Bunch TJ, Dean P, Danielian A, Krishnan S, Baggish AL, Eijsvogels TMH, Chung EH, Levine BD (2021). Exercise-Induced Cardiovascular Adaptations and Approach to Exercise and Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol, 78(14), 1453-1470.
- Kanitsoraphan C, Techorueangwiwat C, Rattanawong P, Kewcharoen J, Ayinapudi K, Bunch TJ, Groh C, Navaravong L (2021). Zero fluoroscopy approach versus fluoroscopy approach for cardiac arrhythmia ablations: A systematic review and meta-analysis. J Cardiovasc Electrophysiol, 32(10), 2761-2776.
- Burnham TS, Scott ML, Steinberg BA, Varela DL, Zenger B, Bunch TJ (2021). Impact of Catheter Ablation on Stroke, Cognitive Decline and Dementia. Arrhythm Electrophysiol Rev, 10(3), 205-210.
- Kewcharoen J, Prasitlumkum N, Chokesuwattanaskul R, Yi R, Jongnarangsin K, Bunch TJ, Ranjan R, Navaravong L (2021). Ablation versus medication as initial therapy for paroxysmal atrial fibrillation: An updated meta-analysis of randomized controlled trials. J Arrhythm, 37(6), 1448-1458.
- Burnham TS, May HT, Bair TL, Anderson JA, Crandall BG, Cutler MJ, Day JD, Freedman RA, Knowlton KU, Muhlestein JB, Navaravong L, Ranjan RA, Steinberg BA, Bunch TJ (2021). Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease. Am Heart J, 243, 127-139.
- Rizzi SA, Knight S, May HT, Woller SC, Stevens SM, Steinberg BA, Bair TL, Anderson JL, Muhlestein JB, Knowlton KU, Bunch TJ (2021). Depression as a Driving Force for Low Time in Therapeutic Range and Dementia in Patients With and Without Atrial Fibrillation. Am J Cardiol, 153, 58-64.
- Steinberg BA, Zhang M, Bensch J, Lyons A, Bunch TJ, Piccini JP, Siu A, Spertus JA, Stehlik J, Wohlfahrt P, Greene T, Hess R, Fang JC (2021). Quantifying the Impact of Atrial Fibrillation on Heart Failure-Related Patient-Reported Outcomes in the Utah mEVAL Program. J Card Fail, 28, 13-20.
- Kamali R, Kump J, Ghafoori E, Lange M, Hu N, Bunch TJ, Dosdall DJ, Macleod RS, Ranjan R (2021). Area Available for Atrial Fibrillation to Propagate Is an Important Determinant of Recurrence After Ablation. JACC Clin Electrophysiol, 7(7), 896-908.
- Gakenheimer-Smith L, Meyers L, Lundahl D, Menon SC, Bunch TJ, Sawyer BL, Tristani-Firouzi M, Etheridge SP (2021). Expanding the phenotype of CACNA1C mutation disorders. Mol Genet Genomic Med, 9(6), e1673.
- Turner JL, Steinberg BA, Bunch TJ, Ranjan R (2021). Inflammatory cutaneous reaction to a temporary permanent pacemaker. HeartRhythm Case Rep, 7(8), 571-572.
- Steinberg BA, Li Z, OBrien EC, Pritchard J, Chew DS, Bunch TJ, Mark DB, Nabutovsky Y, Greiner MA, Piccini JP (2021). Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devices. Heart Rhythm, 18(5), 709-716.
- Duncker D, Ding WY, Etheridge S, Noseworthy PA, Veltmann C, Yao X, Bunch TJ, Gupta D (2021). Smart Wearables for Cardiac Monitoring-Real-World Use beyond Atrial Fibrillation. Sensors (Basel), 21(7).
- Kewcharoen J, Vutthikraivit W, Rattanawong P, Prasitlumkum N, Akoum NW, Bunch TJ, Navaravong L (2020). Renal sympathetic denervation in addition to pulmonary vein isolation reduces the recurrence rate of atrial fibrillation: an updated meta-analysis of randomized control trials. J Interv Card Electrophysiol, 60(3), 459-467.
- Aguilar M, Tedrow UB, Tzou WS, Tung R, Frankel DS, Santangeli P, Vaseghi M, Bunch TJ, Di Biase L, Tholakanahalli VN, Lakkireddy D, Dickfeld T, Weiss JP, Mathuria N, Vergara P, Nakahara S, Bradfield JS, Burkhardt JD, Stevenson WG, Callans DJ, Della Bella P, Natale A, Shivkumar K, Marchlinski FE, Sauer WH (2021). Catheter ablation of ventricular tachycardia in patients with prior cardiac surgery: An analysis from the International VT Ablation Center Collaborative Group. J Cardiovasc Electrophysiol, 32(2), 409-416.
- Basu-Ray I, Khanra D, Kup P, Bunch J, Theus SA, Mukherjee A, Shah SK, Komcsi A, Adeboye A, Jefferies J (2021). Outcomes of uninterrupted vs interrupted Periprocedural direct oral Anticoagulants in atrial Fibrillation ablation: A meta-analysis. J Arrhythm, 37(2), 384-393.
- Kewcharoen J, Techorueangwiwat C, Kanitsoraphan C, Leesutipornchai T, Akoum N, Bunch TJ, Navaravong L (2020). High-power short duration and low-power long duration in atrial fibrillation ablation: A meta-analysis. J Cardiovasc Electrophysiol, 32(1), 71-82.
- Basu-Ray I, Khanra D, Shah SK, Mukherjee A, Char SV, Jain B, Bunch TJ, Gold M, Adeboye AA, Saeed M (2020). Meta-analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy. Pacing Clin Electrophysiol, 44(1), 54-62.
- Sepehri Shamloo A, Bunch TJ, Lin YJ, de Oliveira Figueiredo MJ, Dagres N, Nielsen JC (2020). Risk Assessment in Cardiac Arrhythmias. Eur Heart J, 41(47), 4455-4457.
- Zenger B, Zhang M, Lyons A, Bunch TJ, Fang JC, Freedman RA, Navaravong L, Piccini JP, Ranjan R, Spertus JA, Stehlik J, Turner JL, Greene T, Hess R, Steinberg BA (2020). Patient-reported outcomes and subsequent management in atrial fibrillation clinical practice: Results from the Utah mEVAL AF program. J Cardiovasc Electrophysiol, 31(12), 3187-3195.
- Zenger B, Swink JM, Turner JL, Bunch TJ, Ryan JJ, Shah RU, Turakhia MP, Piccini JP, Steinberg BA (2020). Social Media Influence Does Not Reflect Scholarly or Clinical Activity in Real Life. Circ Arrhythm Electrophysiol, 13(11), e008847.
- Piccini JP Sr, Allred J, Bunch TJ, Deering TF, Di Biase L, Hussein AA, Lewis WR, Mittal S, Natale A, Osorio J, Packer DL, Ruff C, Russo AM, Sanders P, Seiler A, Slotwiner D, Hills MT, Turakhia MP, Van Gelder IC, Varosy PD, Verma A, Volgman AS, Wood KA, Deneke T (2020). Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective. Heart Rhythm, 17(10), 1804-1832.
- Bunch TJ (2020). Atrial Fibrillation and Dementia. Circulation, 142(7), 618-620.
- Muhlestein JB, Anderson JL, Bethea CF, Severance HW, Mentz RJ, Barsness GW, Barbagelata A, Albert D, Le VT, Bunch TJ, Yanowitz F, May HT, Chisum B, Ronnow BS, Muhlestein JB, Duke University Cooperative Cardiovascular Society DUCCS investigators (2019). Feasibility of combining serial smartphone single-lead electrocardiograms for the diagnosis of ST-elevation myocardial infarction. Am Heart J, 221, 125-135.
- Proietti R, AlTurki A, Vio R, Licchelli L, Rivezzi F, Marafi M, Russo V, Potpara TS, Kalman JM, de Villers-Sidani E, Bunch TJ (2019). The association between atrial fibrillation and Alzheimer's disease: fact or fallacy? A systematic review and meta-analysis. J Cardiovasc Med (Hagerstown), 21(2), 106-112.
- Bunch TJ, Bair TL, Crandall BG, Cutler MJ, Day JD, Graves KG, Jacobs V, Mallender C, Osborn JS, Weiss JP, May HT (2019). Stroke and dementia risk in patients with and without atrial fibrillation and carotid arterial disease. Heart Rhythm, 17(1), 20-26.
- Anderson JL, Jacobs V, May HT, Bair TL, Benowitz BA, Lappe DL, Muhlestein JB, Knowlton KU, Bunch TJ (2019). Free thyroxine within the normal reference range predicts risk of atrial fibrillation. J Cardiovasc Electrophysiol, 31(1), 18-29.
- Slotwiner DJ, Abraham RL, Al-Khatib SM, Anderson HV, Bunch TJ, Ferrara MG, Lippman N, Serwer GA, Steiner PR, Tcheng JE, Varma N, Wilkoff BL (2019). HRS White Paper on interoperability of data from cardiac implantable electronic devices (CIEDs). Heart Rhythm, 16(9), e107-e127.
- Horne BD, Jacobs V, May HT, Graves KG, Bunch TJ (2019). Augmented intelligence decision tool for stroke prediction combines factors from CHA2 DS2 -VASc and the intermountain risk score for patients with atrial fibrillation. J Cardiovasc Electrophysiol, 30(9), 1452-1461.
- Bunch TJ (2019). EP News: Case Reports. Heart Rhythm.
- Saglietto A, Matta M, Gaita F, Jacobs V, Bunch TJ, Anselmino M (2019). Stroke-independent contribution of atrial fibrillation to dementia: a meta-analysis. Open Heart, 6(1), e000984.
- Bunch TJ, May HT, Afshar K, Alharethi R, Day JD (2019). Mechanisms of Improved Mortality Following Ablation: Does Ablation Restore Beta-Blocker Benefit in Atrial Fibrillation/Heart Failure? Cardiol Clin, 37(2), 177-183.
- Bunch TJ, Jacobs V, May H, Stevens SM, Crandall B, Cutler M, Day JD, Mallender C, Olson J, Osborn J, Weiss JP, Woller SC (2019). Rationale and design of the impact of anticoagulation therapy on the Cognitive Decline and Dementia in Patients with Nonvalvular Atrial Fibrillation (CAF) Trial: A Vanguard study. Clin Cardiol, 42(5), 506-512.
- Jacobs V, T May H, L Bair T, G Crandall B, J Cutler DO M, D Day J, Le V, Mallender C, S Osborn J, Weiss JP, Bunch TJ (2019). The Impact of Repeated Cardioversions for Atrial Fibrillation on Stroke, Hospitalizations, and Catheter Ablation Outcomes. J Atr Fibrillation, 11(6), 2164.
- Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL, CABANA Investigators (2019). Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA, 321, 1261-1274.
- Turagam MK, Atoui M, Atkins D, Di Biase L, Shivkumar K, Jared Bunch T, Mohanty S, Gianni C, Natale A, Lakkireddy D (2018). Persistent left superior vena cava as an arrhythmogenic source in atrial fibrillation: results from a multicenter experience. J Interv Card Electrophysiol, 54(2), 93-100.
- Bunch TJ, Galenko O, Graves KG, Jacobs V, May HT (2019). Atrial Fibrillation and Dementia: Exploring the Association, Defining Risks and Improving Outcomes. Arrhythm Electrophysiol Rev, 8(1), 8-12.
- Galenko O, Jacobs V, Knight S, Taylor M, Cutler MJ, Muhlestein JB, Carlquist JL, Knowlton KU, Jared Bunch T (2019). The role of microRNAs in the development, regulation, and treatment of atrial fibrillation. J Interv Card Electrophysiol.
- Bunch TJ (2018). Too much, too little, or just right?: Applying the Goldilocks principle to cryoballoon ablation for atrial fibrillation. J Cardiovasc Electrophysiol, 30(1), 25-26.
- Graves KG, May HT, Jacobs V, Knowlton KU, Muhlestein JB, Lappe DL, Anderson JL, Horne BD, Bunch TJ (2018). CHA2DS2-VASc scores and Intermountain Mortality Risk Scores for the joint risk stratification of dementia among patients with atrial fibrillation. Heart Rhythm, 16(1), 3-9.
- Vergara P, Tzou WS, Tung R, Brombin C, Nonis A, Vaseghi M, Frankel DS, Di Biase L, Tedrow U, Mathuria N, Nakahara S, Tholakanahalli V, Bunch TJ, Weiss JP, Dickfeld T, Lakireddy D, Burkhardt JD, Santangeli P, Callans D, Natale A, Marchlinski F, Stevenson WG, Shivkumar K, Sauer WH, Della Bella P (2019). Predictive Score for Identifying Survival and Recurrence Risk Profiles in Patients Undergoing Ventricular Tachycardia Ablation. Circ Arrhythm Electrophysiol, 11(12), e006730.
- Graves KG, May HT, Knowlton KU, Muhlestein JB, Jacobs V, Lapp DL, Anderson JL, Horne BD, Bunch TJ (2018). Improving CHA2DS2-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation. Open Heart, 5(2), e000907.
- Toso E, Peyracchia M, Matta M, DAscenzo F, Gaita F, Kornej J, Hindricks G, Jared Bunch T, Saliba W (2018). Incidence of thromboembolic events following atrial fibrillation catheter ablation and rate control strategies according to the kind of oral anticoagulation: A systematic review and meta-analysis. Int J Cardiol, 270, 172-179.
- Golive A, May HT, Bair TL, Jacobs V, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Weiss JP, Bunch TJ (2018). The Impact of Gender on Atrial Fibrillation Incidence and Progression to Dementia. Am J Cardiol, 122(9), 1489-1495.
- Basu-Ray I, Sudhakar D, Schwing G, Monlezun D, Zhang L, Shah SK, Pujara D, Ting K, Rafeh NA, Ali G, Cassidy M, Ellenbogen K, Levine G, Lam W, Mathuria N, Saeed M, Bunch J, Martin-Schild S, Gold M, Aryana A, Razavi M, Rasekh A (2018). Complex Left Atrial Appendage Morphology Is an Independent Risk Factor for Cryptogenic Ischemic Stroke. Front Cardiovasc Med, 5, 131.
- Vaseghi M, Hu TY, Tung R, Vergara P, Frankel DS, Di Biase L, Tedrow UB, Gornbein JA, Yu R, Mathuria N, Nakahara S, Tzou WS, Sauer WH, Burkhardt JD, Tholakanahalli VN, Dickfeld TM, Weiss JP, Bunch TJ, Reddy M, Callans DJ, Lakkireddy DR, Natale A, Marchlinski FE, Stevenson WG, Della Bella P, Shivkumar K (2018). Outcomes of Catheter Ablation of Ventricular Tachycardia Based on Etiology in Nonischemic Heart Disease: An International Ventricular Tachycardia Ablation Center Collaborative Study. JACC Clin Electrophysiol, 4(9), 1141-1150.
- Horne BD, Muhlestein JB, Bennett ST, Muhlestein JB, Jensen KR, Marshall D, Bair TL, May HT, Carlquist JF, Hegewald M, Knight S, Le VT, Bunch TJ, Lapp DL, Anderson JL, Knowlton KU (2018). Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality. JCI Insight, 3(14).
- Chatterjee NA, Moorthy MV, Pester J, Schaecter A, Panicker GK, Narula D, Lee DC, Goldberger JJ, Kadish A, Cook NR, Albert CM, PRE-DETERMINE Study Group (2018). Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction. JAMA Cardiol, 3(7), 591-600.
- Mujovi N, Marinkovi M, Markovi N, Vuievi V, Lip GYH, Bunch TJ, Potpara TS (2018). The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set. Sci Rep, 8(1), 9875.
- Turakhia MP, Blankestijn PJ, Carrero JJ, Clase CM, Deo R, Herzog CA, Kasner SE, Passman RS, Pecoits-Filho R, Reinecke H, Shroff GR, Zareba W, Cheung M, Wheeler DC, Winkelmayer WC, Wanner C, Conference Participants (2017). Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Eur Heart J, 39(24), 2314-2325.
- Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Mrquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK (2018). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? Heart Rhythm, 15(6), e37-e60.
- Mansour M, Heist EK, Agarwal R, Bunch TJ, Karst E, Ruskin JN, Mahapatra S (2018). Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation. Am J Cardiol, 121(10), 1192-1199.
- Jacobs V, May HT, Crandall BG, Ballantyne B, Chisum B, Johnson D, Graves KG, Cutler M, Day JD, Mallender C, Osborn JS, Weiss JP, Bunch TJ (2018). Vagus nerve injury symptoms after catheter ablation for atrial fibrillation. Pacing Clin Electrophysiol, 41(4), 389-395.
- Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Mrquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK, Bautista-Vargas WF, Chiang CE, Cuesta A, Dan GA, Frankel DS, Guo Y, Hatala R, Lee YS, Murakawa Y, Pellegrini CN, Pinho C, Milan DJ, Morin DP, Nadalin E, Ntaios G, Prabhu MA, Proietti M, Rivard L, Valentino M, Shantsila A (2018). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice? J Arrhythm, 34(2), 99-123.
- Winterfield JR, Kent AR, Karst E, Dalal N, Mahapatra S, Bunch TJ, Reynolds MR, Wilber DJ (2017). Impact of ventricular tachycardia ablation on health care utilization. Heart Rhythm, 15(3), 355-362.
- Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Jacobs V, Mallender C, Osborn JS, Weiss JP (2017). Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke. J Cardiovasc Electrophysiol, 29(2), 221-226.
- Tracy CM, Crossley GH, Bunch TJ, Chow GV, Leiserowitz A, Indik JH, Kusumoto F, Mendes LA, Munger TM, Murali S, Patton KK, Russo AM, Scheinman M, Schoenhard JA, Winterfield JR (2017). 2017 ACC/HRS lifelong learning statement for clinical cardiac electrophysiology specialists: A report of the ACC Competency Management Committee. Heart Rhythm, 15(2), e17-e34.
- Graves KG, Jacobs V, May HT, Cutler MJ, Day JD, Bunch TJ (2018). Atrial Fibrillation Ablation and its Impact on Stroke. Curr Treat Options Cardiovasc Med, 20(1), 2.
- Tracy CM, Crossley GH, Bunch TJ, Chow GV, Leiserowitz A, Indik JH, Kusumoto F, Mendes LA, Munger TM, Murali S, Patton KK, Russo AM, Scheinman M, Schoenhard JA, Winterfield JR (2017). 2017 ACC/HRS Lifelong Learning Statement for Clinical Cardiac Electrophysiology Specialists: A Report of the ACC Competency Management Committee. J Am Coll Cardiol, 71(2), 231-250.
- Vergara P, Tung R, Vaseghi M, Brombin C, Frankel DS, Di Biase L, Nagashima K, Tedrow U, Tzou WS, Sauer WH, Mathuria N, Nakahara S, Vakil K, Tholakanahalli V, Bunch TJ, Weiss JP, Dickfeld T, Vunnam R, Lakireddy D, Burkhardt JD, Correra A, Santangeli P, Callans D, Natale A, Marchlinski F, Stevenson WG, Shivkumar K, Della Bella P (2017). Successful ventricular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival. Heart Rhythm, 15(1), 48-55.
- Barbagelata A, Bethea CF, Severance HW, Mentz RJ, Albert D, Barsness GW, Le VT, Anderson JL, Bunch TJ, Yanowitz F, Chisum B, Ronnow BS, Muhlestein JB (2017). Smartphone ECG for evaluation of ST-segment elevation myocardial infarction (STEMI): Design of the ST LEUIS International Multicenter Study. J Electrocardiol, 51(2), 260-264.
- Turagam MK, Vuddanda V, Atkins D, Santangeli P, Frankel DS, Tung R, Vaseghi M, Sauer WH, Tzou W, Mathuria N, Nakahara S, Dickfeld TM, Bunch TJ, Weiss P, Di Biase L, Tholakanahalli V, Vakil K, Tedrow UB, Stevenson WG, Della Bella P, Shivkumar K, Marchlinski FE, Callans DJ, Natale A, Reddy M, Lakkireddy D (2017). Hemodynamic Support in Ventricular Tachycardia Ablation: An International VT Ablation Center Collaborative Group Study. JACC Clin Electrophysiol, 3(13), 1534-1543.
- Mujovi N, Marinkovi M, Markovi N, Stankovi G, Lip GYH, Blomstrom-Lundqvist C, Bunch TJ, Potpara TS (2017). Persistency of left atrial linear lesions after radiofrequency catheter ablation for atrial fibrillation: Data from an invasive follow-up electrophysiology study. J Cardiovasc Electrophysiol, 28(12), 1403-1414.
- Mason S, Osborn JS, Dhar R, Tonkin A, Ethington JD, Le V, Benuzillo J, Lappe DL, Knowlton KU, Bunch TJ, Anderson JL (2017). Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafe. J Cardiovasc Electrophysiol, 28(12), 1468-1474.
- Jacobs V, Graves KG, Bunch TJ (2017). Anticoagulant use in atrial fibrillation and risk of dementia: review of contemporary knowledge. Expert Rev Cardiovasc Ther, 15(12), 897-903.
- Vakil K, Garcia S, Tung R, Vaseghi M, Tedrow U, Della Bella P, Frankel DS, Vergara P, Di Biase L, Nagashima K, Nakahara S, Tzou WS, Burkhardt JD, Dickfeld T, Weiss JP, Bunch J, Callans D, Lakkireddy D, Natale A, Sauer WH, Stevenson WG, Marchlinski F, Shivkumar K, Tholakanahalli VN (2017). Ventricular Tachycardia Ablation in the Elderly: An International Ventricular Tachycardia Center Collaborative Group Analysis. Circ Arrhythm Electrophysiol, 10(12).
- Aryana A, dAvila A, Cool CL, Miller MA, Garcia FC, Supple GE, Dukkipati SR, Lakkireddy D, Bunch TJ, Bowers MR, ONeill PG, Reddy VY, Marchlinski FE (2017). Outcomes of catheter ablation of ventricular tachycardia with mechanical hemodynamic support: An analysis of the Medicare database. J Cardiovasc Electrophysiol, 28(11), 1295-1302.
- Jacobs V, May HT, Bair TL, Crandall BG, Cutler DO MJ, Day JD, Mallender C, Osborn JS, Weiss JP, Bunch TJ (2017). Long-term aspirin does not lower risk of stroke and increases bleeding risk in low-risk atrial fibrillation ablation patients. J Cardiovasc Electrophysiol, 28(11), 1241-1246.
- Afshar K, Bunch TJ (2017). Return-to-Play in 2017 and the Role of Shared Decision-Making in Patients with Inherited and Acquired Channelopathies and Cardiomyopathies. Curr Treat Options Cardiovasc Med, 19(10), 75.
- Anselmino M, Matta M, Bunch TJ, Fiala M, Scaglione M, Nlker G, Qian P, Neumann T, Ferraris F, Gaita F (2017). Conduction recovery following catheter ablation in patients with recurrent atrial fibrillation and heart failure. Int J Cardiol, 240, 240-245.
- Golive A, May HT, Bair TL, Jacobs V, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller SC, Bunch TJ (2017). The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation. Am J Cardiol, 120(1), 75-82.
- Tzou WS, Tung R, Frankel DS, Di Biase L, Santangeli P, Vaseghi M, Bunch TJ, Weiss JP, Tholakanahalli VN, Lakkireddy D, Vunnam R, Dickfeld T, Mathuria N, Tedrow U, Vergara P, Vakil K, Nakahara S, Burkhardt JD, Stevenson WG, Callans DJ, Della Bella P, Natale A, Shivkumar K, Marchlinski FE, Sauer WH (2017). Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group. Heart Rhythm, 14(7), 991-997.
- Santangeli P, Frankel DS, Tung R, Vaseghi M, Sauer WH, Tzou WS, Mathuria N, Nakahara S, Dickfeldt TM, Lakkireddy D, Bunch TJ, Di Biase L, Natale A, Tholakanahalli V, Tedrow UB, Kumar S, Stevenson WG, Della Bella P, Shivkumar K, Marchlinski FE, Callans DJ, International VT Ablation Center Collaborative Group (2016). Early Mortality After Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease. J Am Coll Cardiol, 69(17), 2105-2115.
- Tzou WS, Tung R, Frankel DS, Vaseghi M, Bunch TJ, Di Biase L, Tholakanahalli VN, Lakkireddy D, Dickfeld T, Saliaris A, Weiss JP, Mathuria N, Tedrow U, Afzal MR, Vergara P, Nagashima K, Patel M, Nakahara S, Vakil K, Burkhardt JD, Tseng CH, Natale A, Shivkumar K, Callans DJ, Stevenson WG, Della Bella P, Marchlinski FE, Sauer WH (2016). Ventricular Tachycardia Ablation in Severe Heart Failure: An International Ventricular Tachycardia Ablation Center Collaboration Analysis. Circ Arrhythm Electrophysiol, 10(1).
- Frankel DS, Tung R, Santangeli P, Tzou WS, Vaseghi M, Di Biase L, Nagashima K, Tedrow U, Bunch TJ, Tholakanahalli VN, Dendi R, Reddy M, Lakkireddy D, Dickfeld T, Weiss JP, Mathuria N, Vergara P, Patel M, Nakahara S, Vakil K, Sauer WH, Callans DJ, Natale A, Stevenson WG, Della Bella P, Shivkumar K, Marchlinski FE (2016). Sex and Catheter Ablation for Ventricular Tachycardia: An International Ventricular Tachycardia Ablation Center Collaborative Group Study. JAMA Cardiol, 1(8), 938-944.
- Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Jacobs V, Mallender C, Muhlestein JB, Osborn JS, Weiss JP, Day JD (2016). Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation. J Interv Card Electrophysiol, 46(3), 259-65.
- Knight S, McCubrey RO, Yuan Z, Woller SC, Horne BD, Bunch TJ, Le VT, Mills RM, Muhlestein JB (2016). Adverse cardiovascular events in acute coronary syndrome with indications for anticoagulation. Ther Adv Cardiovasc Dis, 10(4), 231-41.
- Jacobs V, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller SC, Bunch TJ (2016). Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation. Am J Cardiol, 118(2), 210-4.
- Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Jacobs V, Mallender C, Osborn JS, Stevens SM, Weiss JP, Woller SC (2016). Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications. J Am Heart Assoc, 5(7).
- Bunch J (2016). MY APPROACH to a patient with atrial fibrillation and dementia. Trends Cardiovasc Med, 26(3), 293-4.
- Lappe JM, Cutler MJ, Day JD, Bunch TJ (2016). Ablation for Persistent Atrial Fibrillation-Is There a Role for More Than PVI? Curr Treat Options Cardiovasc Med, 18(3), 15.
- Weiss JP, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Osborn JS, Mallender C, Bunch TJ (2015). A Comparison of Remote Magnetic Irrigated Tip Ablation versus Manual Catheter Irrigated Tip Catheter Ablation With and Without Force Sensing Feedback. J Cardiovasc Electrophysiol, 27 Suppl 1, S5-S10.
- Bunch TJ, May HT, Bair TL, Jacobs V, Crandall BG, Cutler M, Weiss JP, Mallender C, Osborn JS, Anderson JL, Day JD (2015). The Impact of Age on 5-Year Outcomes After Atrial Fibrillation Catheter Ablation. J Cardiovasc Electrophysiol, 27(2), 141-6.
- Carlquist JF, Knight S, Cawthon RM, Le VT, Jared Bunch T, Horne BD, Rollo JS, Huntinghouse JA, Brent Muhlestein J, Anderson JL (2015). Shortened telomere length is associated with paroxysmal atrial fibrillation among cardiovascular patients enrolled in the Intermountain Heart Collaborative Study. Heart Rhythm, 13(1), 21-7.
- Bunch TJ, May HT, Bair TL, Anderson JL, Crandall BG, Cutler MJ, Jacobs V, Mallender C, Muhlestein JB, Osborn JS, Weiss JP, Day JD (2015). Long-Term Natural History of Adult Wolff-Parkinson-White Syndrome Patients Treated With and Without Catheter Ablation. Circ Arrhythm Electrophysiol, 8(6), 1465-71.
- Jacobs V, Woller SC, Stevens SM, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Mallender C, Anderson JL, Bunch TJ (2015). Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of Dementia. J Cardiovasc Electrophysiol, 26(11), 1180-1186.
- Reiffel JA, Camm AJ, Belardinelli L, Zeng D, Karwatowska-Prokopczuk E, Olmsted A, Zareba W, Rosero S, Kowey P, HARMONY Investigators (2015). The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism. Circ Arrhythm Electrophysiol, 8(5), 1048-56.
- Anselmino M, Matta M, Dascenzo F, Pappone C, Santinelli V, Bunch TJ, Neumann T, Schilling RJ, Hunter RJ, Noelker G, Fiala M, Frontera A, Thomas G, Katritsis D, Jais P, Weerasooriya R, Kalman JM, Gaita F (2015). Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis. Europace, 17(10), 1518-25.
- Reddy VY, Exner DV, Cantillon DJ, Doshi R, Bunch TJ, Tomassoni GF, Friedman PA, Estes NA 3rd, Ip J, Niazi I, Plunkitt K, Banker R, Porterfield J, Ip JE, Dukkipati SR, LEADLESS II Study Investigators (2015). Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. N Engl J Med, 373(12), 1125-35.
- Tung R, Vaseghi M, Frankel DS, Vergara P, Di Biase L, Nagashima K, Yu R, Vangala S, Tseng CH, Choi EK, Khurshid S, Patel M, Mathuria N, Nakahara S, Tzou WS, Sauer WH, Vakil K, Tedrow U, Burkhardt JD, Tholakanahalli VN, Saliaris A, Dickfeld T, Weiss JP, Bunch TJ, Reddy M, Kanmanthareddy A, Callans DJ, Lakkireddy D, Natale A, Marchlinski F, Stevenson WG, Della Bella P, Shivkumar K (2015). Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. Heart Rhythm, 12(9), 1997-2007.
- Calkins H, Awtry EH, Bunch TJ, Kaul S, Miller JM, Tedrow UB (2015). COCATS 4 Task Force 11: Training in Arrhythmia Diagnosis and Management, Cardiac Pacing, and Electrophysiology. J Am Coll Cardiol, 65(17), 1854-65.
- Bunch TJ, May HT, Bair TL, Jacobs V, Crandall BG, Cutler M, Weiss JP, Mallender C, Osborn JS, Anderson JL, Day JD (2015). Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction. J Cardiovasc Electrophysiol, 26(4), 363-370.
- Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ (2014). The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Heart Rhythm, 12(4), 681-6.
- Kanmanthareddy A, Vallakati A, Reddy Yeruva M, Dixit S, DI Biase L, Mansour M, Boolani H, Gunda S, Bunch TJ, Day JD, Ruskin JN, Buddam A, Koripalli S, Bommana S, Natale A, Lakkireddy D (2015). Pulmonary vein isolation for atrial fibrillation in the postpneumonectomy population: a feasibility, safety, and outcomes study. J Cardiovasc Electrophysiol, 26(4), 385-389.
- Sheldon SH, Bunch TJ, Cogert GA, Acker NG, Dalzell CM, Higgins JV, Espinosa RE, Asirvatham SJ, Cha YM, Felmlee JP, Watson RE Jr, Anderson JL, Brooks MH, Osborn JS, Friedman PA (2014). Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leads. Heart Rhythm, 12(2), 345-9.
- Rollo J, Knight S, May HT, Anderson JL, Muhlestein JB, Bunch TJ, Carlquist J (2014). Incidence of dementia in relation to genetic variants at PITX2, ZFHX3, and ApoE ε4 in atrial fibrillation patients. Pacing Clin Electrophysiol, 38(2), 171-7.
- Bunch TJ, Cutler MJ (2014). Is pulmonary vein isolation still the cornerstone in atrial fibrillation ablation? J Thorac Dis, 7(2), 132-41.
- Jacobs V, Cutler MJ, Day JD, Bunch TJ (2014). Atrial fibrillation and dementia. Trends Cardiovasc Med, 25(1), 44-51.
- Knight S, Klaskala W, Woller SC, Horne BD, Bunch TJ, Le VT, Mills RM, Muhlestein JB (2015). Antithrombotic therapy in patients with acute coronary syndrome in the intermountain heart collaborative study. Cardiol Res Pract, 2015, 270508.
- Jacobs V, Woller SC, Stevens S, May HT, Bair TL, Anderson JL, Crandall BG, Day JD, Johanning K, Long Y, Mallender C, Olson JL, Osborn JS, Weiss JP, Bunch TJ (2014). Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia. Heart Rhythm, 11(12), 2206-13.
- Anselmino M, Matta M, DAscenzo F, Bunch TJ, Schilling RJ, Hunter RJ, Pappone C, Neumann T, Noelker G, Fiala M, Bertaglia E, Frontera A, Duncan E, Nalliah C, Jais P, Weerasooriya R, Kalman JM, Gaita F (2014). Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol, 7(6), 1011-8.
- Brunner KJ, Bunch TJ, Mullin CM, May HT, Bair TL, Elliot DW, Anderson JL, Mahapatra S (2014). Clinical predictors of risk for atrial fibrillation: implications for diagnosis and monitoring. Mayo Clin Proc, 89(11), 1498-505.
- Whisenant B, Kar S, Bunch TJ (2014). Left atrial appendage occlusion addresses the tremendous unmet needs of stroke prevention in atrial fibrillation that persist despite recent advances in anticoagulation therapy. Circulation, 130(17), 1516-23.
- Tong CW, Ahmad T, Brittain EL, Bunch TJ, Damp JB, Dardas T, Hijar A, Hill JA, Hilliard AA, Houser SR, Jahangir E, Kates AM, Kim D, Lindman BR, Ryan JJ, Rzeszut AK, Sivaram CA, Valente AM, Freeman AM (2014). Challenges facing early career academic cardiologists. J Am Coll Cardiol, 63(21), 2199-208.
- Bunch TJ, Anderson JL (2013). Adjuvant antiarrhythmic therapy in patients with implantable cardioverter defibrillators. Am J Cardiovasc Drugs, 14(2), 89-100.
- Bunch TJ, Weiss JP, Crandall BG, Day JD, May HT, Bair TL, Osborn JS, Mallender C, Fischer A, Brunner KJ, Mahapatra S (2013). Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only. Heart Rhythm, 11(4), 533-40.
- Reddy YM, Chinitz L, Mansour M, Bunch TJ, Mahapatra S, Swarup V, Di Biase L, Bommana S, Atkins D, Tung R, Shivkumar K, Burkhardt JD, Ruskin J, Natale A, Lakkireddy D (2014). Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience. Circ Arrhythm Electrophysiol, 7(2), 244-50.
- Bunch TJ (2013). Elderly in-hospital cardiac arrest patients who are resuscitated with neurological recovery experience favourable long-term survival similar to non-arrest heart failure patients. Evid Based Med, 18(6), 227-8.
- Bunch TJ, May HT, Bair TL, Johnson DL, Weiss JP, Crandall BG, Osborn JS, Anderson JL, Muhlestein JB, Lappe DL, Day JD (2013). Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes. Heart Rhythm, 10(9), 1257-62.
- Bunch TJ, May HT, Bair TL, Weiss JP, Crandall BG, Osborn JS, Mallender C, Anderson JL, Muhlestein BJ, Lappe DL, Day JD (2013). Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. Heart Rhythm, 10(9), 1272-7.
- Roy RR, Sagar S, Bunch TJ, Aman W, Crusan DJ, Srivathsan K, Asirvatham SJ, Shen WK, Jahangir A (2013). Hiatal Hernia Is Associated With an Increased Prevalence of Atrial Fibrillation in Young Patients. J Atr Fibrillation, 6(2), 894.
- Horne BD, Lapp DL, Muhlestein JB, May HT, Ronnow BS, Brunisholz KD, Kfoury AG, Bunch TJ, Alharethi R, Budge D, Whisenant BK, Bair TL, Jensen KR, Anderson JL (2013). Repeated measurement of the intermountain risk score enhances prognostication for mortality. PLoS One, 8(7), e69160.
- Labedi MR, Alharethi R, Kfoury AG, Budge D, Bruce R, Rasmusson B, Bunch TJ (2013). Electromagnetic interference of automatic implantable cardioverter defibrillator and HeartWare left ventricular assist device. ASAIO J, 59(2), 136-9.
- Bunch TJ, May HT, Crandall BG, Weiss JP, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Lappe DL, Johnson DL, Day JD (2012). Intracardiac ultrasound for esophageal anatomic assessment and localization during left atrial ablation for atrial fibrillation. J Cardiovasc Electrophysiol, 24(1), 33-9.
- Johnson DL, Day JD, Doty JR, Bunch TJ (2012). Atrial fibrillation and atrial flutter: nonpharmacologic therapy. Clin Geriatr Med, 28(4), 649-63.
- Brann A, Day JD, Bunch TJ (2016). The Role of Anticoagulation in a Patient with Atrial Fibrillation and a CHADS2 Score of 1. Card Electrophysiol Clin, 4(2), 107-17.
- Bunch TJ, Darby A, May HT, Ragosta M, Lim DS, Taylor AM, DiMarco JP, Ailawadi G, Revenaugh JR, Weiss JP, Mahapatra S (2011). Efficacy and safety of ventricular tachycardia ablation with mechanical circulatory support compared with substrate-based ablation techniques. Europace, 14(5), 709-14.
- Bunch TJ, Mahapatra S, Murdock D, Molden J, Weiss JP, May HT, Bair TL, Mader KM, Crandall BG, Day JD, Osborn JS, Muhlestein JB, Lappe DL, Anderson JL (2011). Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks. Pacing Clin Electrophysiol, 34(12), 1600-6.
- Horne BD, Muhlestein JB, Lapp DL, Brunisholz KD, May HT, Kfoury AG, Carlquist JF, Alharethi R, Budge D, Whisenant BK, Bunch TJ, Ronnow BS, Rasmusson KD, Bair TL, Jensen KR, Anderson JL (2011). The intermountain risk score predicts incremental age-specific long-term survival and life expectancy. Transl Res, 158(5), 307-14.
- Bunch TJ, Horne BD, Asirvatham SJ, Day JD, Crandall BG, Weiss JP, Osborn JS, Anderson JL, Muhlestein JB, Lappe DL, Pope CA 3rd (2011). Atrial fibrillation hospitalization is not increased with short-term elevations in exposure to fine particulate air pollution. Pacing Clin Electrophysiol, 34(11), 1475-9.
- Bunch TJ, May HT, Bair TL, Crandall BG, Weiss JP, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day JD (2011). Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to determine ICD candidacy. Heart Rhythm, 8(9), 1460-6.
- Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day JD (2011). Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol, 22(8), 839-45.
- Malasana G, Day JD, Weiss JP, Crandall BG, Bair TL, May HT, Osborn JS, Anderson JL, Muhlestein JB, Lappe DL, Nelson J, Bunch TJ (2011). A strategy of rapid cardioversion minimizes the significance of early recurrent atrial tachyarrhythmias after ablation for atrial fibrillation. J Cardiovasc Electrophysiol, 22(7), 761-6.
- Bunch TJ, Gersh BJ (2010). Rhythm control strategies and the role of antiarrhythmic drugs in the management of atrial fibrillation: focus on clinical outcomes. J Gen Intern Med, 26(5), 531-7.
- Mahapatra S, LaPar DJ, Bhamidipati CM, McDaniel G, Kamath S, Bunch TJ, Ailawadi G (2011). Incidence, risk factors, and consequences of new-onset atrial fibrillation following epicardial ablation for ventricular tachycardia. Europace, 13(4), 548-54.
- Mirzoyev SA, McLeod CJ, Bunch TJ, Bell MR, White RD (2010). Hypokalemia during the cooling phase of therapeutic hypothermia and its impact on arrhythmogenesis. Resuscitation, 81(12), 1632-6.
- Horne BD, May HT, Kfoury AG, Renlund DG, Muhlestein JB, Lapp DL, Rasmusson KD, Bunch TJ, Carlquist JF, Bair TL, Jensen KR, Ronnow BS, Anderson JL (2010). The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints. Eur J Heart Fail, 12(11), 1203-13.
- Halmek J, Jurk P, Bunch TJ, Lipoldov J, Novk M, Vondra V, Leinveber P, Plachy M, Kara T, Villa M, Frna P, Soucek M, Somers VK, Asirvatham SJ (2010). Use of a novel transfer function to reduce repolarization interval hysteresis. J Interv Card Electrophysiol, 29(1), 23-32.
- Bunch TJ, Weiss JP, Crandall BG, Day JD, DiMarco JP, Ferguson JD, Mason PK, McDaniel G, Osborn JS, Wiggins D, Mahapatra S (2010). Image integration using intracardiac ultrasound and 3D reconstruction for scar mapping and ablation of ventricular tachycardia. J Cardiovasc Electrophysiol, 21(6), 678-84.
- Mahapatra S, Tucker-Schwartz J, Wiggins D, Gillies GT, Mason PK, McDaniel G, Lapar DJ, Stemland C, Sosa E, Ferguson JD, Bunch TJ, Ailawadi G, Scanavacca M (2010). Pressure frequency characteristics of the pericardial space and thorax during subxiphoid access for epicardial ventricular tachycardia ablation. Heart Rhythm, 7(5), 604-9.
- Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day JD (2009). Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart Rhythm, 7(4), 433-7.
- Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, Anderson JL, Lappe DL, Muhlestein JB, Nelson J, Day JD (2009). Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing Clin Electrophysiol, 33(2), 146-52.
- Smith MB, Christensen N, Wang S, Strohecker J, Day JD, Weiss JP, Crandall BG, Osborn JS, Anderson JL, Horne BD, Muhlestein JB, Lappe DL, Moss H, Oliver J, Viau K, Bunch TJ (2010). Warfarin knowledge in patients with atrial fibrillation: implications for safety, efficacy, and education strategies. Cardiology, 116(1), 61-9.
- Ahmadi-Kashani M, Kessler DJ, Day J, Bunch TJ, Stolen KQ, Brown S, Sbaity S, Olshansky B, INTRINSIC RV Study Investigators (2009). Heart rate predicts outcomes in an implantable cardioverter-defibrillator population. Circulation, 120(21), 2040-5.
- Okumura Y, Henz BD, Bunch TJ, Dalegrave C, Johnson SB, Packer DL (2009). Distortion of right superior pulmonary vein anatomy by balloon catheters as a contributor to phrenic nerve injury. J Cardiovasc Electrophysiol, 20(10), 1151-7.
- Malasana G, Day JD, Bunch TJ (2009). Atrial Fibrillation in Hypertrophic Obstructive Cardiomyopathy - Antiarrhythmics, Ablation and More! J Atr Fibrillation, 2(3), 210.
- Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Lappe DL, Muhlestein JB, Nelson J, Allison S, Foley T, Anderson L, Day JD (2009). Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures. J Cardiovasc Electrophysiol, 20(9), 988-93.
- Crandall MA, Horne BD, Day JD, Anderson JL, Muhlestein JB, Crandall BG, Weiss JP, Osborne JS, Lapp DL, Bunch TJ (2009). Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors. Pacing Clin Electrophysiol, 32(8), 981-6.
- Crandall MA, Horne BD, Day JD, Anderson JL, Muhlestein JB, Crandall BG, Weiss JP, Lapp DL, Bunch TJ (2009). Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently. Pacing Clin Electrophysiol, 32(5), 648-52.
- Bunch TJ, Day JD, Packer DL (2008). Insights into energy delivery to myocardial tissue during radiofrequency ablation through application of the first law of thermodynamics. J Cardiovasc Electrophysiol, 20(4), 461-5.
- Bunch TJ, Anderson JL, May HT, Muhlestein JB, Horne BD, Crandall BG, Weiss JP, Lapp DL, Osborn JS, Day JD (2009). Relation of bisphosphonate therapies and risk of developing atrial fibrillation. Am J Cardiol, 103(6), 824-8.
- Bunch TJ, Day JD, Olshansky B, Stolen KQ, Mullin CM, INTRINSIC RV Study Investigators (2008). Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality. Heart Rhythm, 6(1), 2-8.
- Melduni RM, Oh JK, Bunch TJ, Sinak LJ, Gloviczki P (2008). Reconstruction of occluded thoracic duct for treatment of chylopericardium: a novel surgical therapy. J Vasc Surg, 48(6), 1600-2.
- Bunch TJ, Packer DL, Jahangir A, Locke GR, Talley NJ, Gersh BJ, Roy RR, Hodge DO, Asirvatham SJ (2008). Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis. Am J Cardiol, 102(9), 1207-11.
- Bunch TJ, Munger TM, Friedman PA, Asirvatham SJ, Brady PA, Cha YM, Rea RF, Shen WK, Powell BD, Ommen SR, Monahan KH, Haroldson JM, Packer DL (2008). Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol, 19(10), 1009-14.
- Okumura Y, Kolasa MW, Johnson SB, Bunch TJ, Henz BD, OBrien CJ, Miller DV, Packer DL (2008). Mechanism of tissue heating during high intensity focused ultrasound pulmonary vein isolation: implications for atrial fibrillation ablation efficacy and phrenic nerve protection. J Cardiovasc Electrophysiol, 19(9), 945-51.
- Bunch TJ, Ellenbogen KA, Packer DL, Asirvatham SJ (2008). Vagus nerve injury after posterior atrial radiofrequency ablation. Heart Rhythm, 5(9), 1327-30.
- Ahmari SA, Bunch TJ, Modesto K, Stussy V, Dichak A, Seward JB, Pellikka PA, Chandrasekaran K (2008). Impact of individual and cumulative coronary risk factors on coronary flow reserve assessed by dobutamine stress echocardiography. Am J Cardiol, 101(12), 1694-9.
- Bunch TJ, White RD, Lopez-Jimenez F, Thomas RJ (2008). Association of body weight with total mortality and with ICD shocks among survivors of ventricular fibrillation in out-of-hospital cardiac arrest. Resuscitation, 77(3), 351-5.
- Okumura Y, Johnson SB, Bunch TJ, Henz BD, OBrien CJ, Packer DL (2008). A systematical analysis of in vivo contact forces on virtual catheter tip/tissue surface contact during cardiac mapping and intervention. J Cardiovasc Electrophysiol, 19(6), 632-40.
- Okumura Y, Henz BD, Johnson SB, Bunch TJ, OBrien CJ, Hodge DO, Altman A, Govari A, Packer DL (2008). Three-dimensional ultrasound for image-guided mapping and intervention: methods, quantitative validation, and clinical feasibility of a novel multimodality image mapping system. Circ Arrhythm Electrophysiol, 1(2), 110-9.
- Bunch TJ, Day JD (2007). Novel ablative approach for atrial fibrillation to decrease risk of esophageal injury. Heart Rhythm, 5(4), 624-7.
- Bunch TJ, Rihal CS, Gumina RJ, Cooper L, Caplice NM (2008). Progression of nonculprit plaque stenosis following successful percutaneous intervention. Angiology, 59(2), 236-9.
- Srivathsan KS, Bunch TJ, Asirvatham SJ, Edwards WD, Friedman PA, Munger TM, Hammill SC, Cha YM, Brady PA, Jahangir A, Bradley DJ, Rea RF, Packer DL, Shen WK (2009). Mechanisms and utility of discrete great arterial potentials in the ablation of outflow tract ventricular arrhythmias. Circ Arrhythm Electrophysiol, 1(1), 30-8.
- Bunch TJ, Day JD, Anderson JL, Horne BD, Muhlestein JB, Crandall BG, Weiss JP, Lappe DL, Asirvatham SJ (2008). Frequency of helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiography. Am J Cardiol, 101(6), 848-51.
- Bunch TJ, Connolly HM, Asirvatham SJ, Brady PA, Gersh BJ, Munger TM, Shen WK, Monahan KH, Packer DL (2007). Catheter ablation for atrial fibrillation in patients with the Marfan and Marfan-like syndromes. J Interv Card Electrophysiol, 20(1-2), 15-20.
- Bunch TJ, Hohnloser SH, Gersh BJ (2007). Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators. Circulation, 115(18), 2451-7.
- Elesber AA, Lerman A, Denktas AE, Resch ZT, Jared Bunch T, Schwartz RS, Conover CA (2006). Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergency department. Int J Cardiol, 117(3), 365-9.
- Bunch TJ, Chandrasekaran K, Ehrsam JE, Hammill SC, Urban LH, Hodge DO, Ommen SR, Pellikka PA (2007). Prognostic significance of exercise induced arrhythmias and echocardiographic variables in hypertrophic cardiomyopathy. Am J Cardiol, 99(6), 835-8.
- Bunch TJ, Kottke TE, Lopez-Jimenez F, Mahapatra S, Elesber AA, White RD (2006). A comparative analysis of short- and long-term outcomes after ventricular fibrillation out-of-hospital cardiac arrest in patients with ischemic and nonischemic heart disease. Am J Cardiol, 98(7), 857-60.
- Bunch TJ, Mahapatra S, Bruce GK, Johnson SB, Miller DV, Horne BD, Wang XL, Lee HC, Caplice NM, Packer DL (2006). Impact of transforming growth factor-beta1 on atrioventricular node conduction modification by injected autologous fibroblasts in the canine heart. Circulation, 113(21), 2485-94.
- Bunch TJ, Nelson J, Foley T, Allison S, Crandall BG, Osborn JS, Weiss JP, Anderson JL, Nielsen P, Anderson L, Lappe DL, Day JD (2006). Temporary esophageal stenting allows healing of esophageal perforations following atrial fibrillation ablation procedures. J Cardiovasc Electrophysiol, 17(4), 435-9.
- Ahmari SA, Modesto K, Bunch J, Stussy V, Dichak A, Seward J, Pellikka P, Chandrasekaran K (2005). Doppler derived coronary flow reserve during dobutamine stress echocardiography further improves detection of myocardial ischemia. Eur J Echocardiogr, 7(2), 134-40.
- Ahmari SA, Bunch TJ, Chandra A, Chandra V, Ujino K, Daly RC, Kushwaha SS, Edwards BS, Maalouf YF, Seward JB, McGregor CG, Chandrasekaran K (2005). Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. J Heart Lung Transplant, 25(1), 53-60.
- Bunch TJ, Bruce GK, Mahapatra S, Johnson SB, Miller DV, Sarabanda AV, Milton MA, Packer DL (2006). Mechanisms of phrenic nerve injury during radiofrequency ablation at the pulmonary vein orifice. J Cardiovasc Electrophysiol, 16(12), 1318-25.
- Sarabanda AV, Bunch TJ, Johnson SB, Mahapatra S, Milton MA, Leite LR, Bruce GK, Packer DL (2005). Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. J Am Coll Cardiol, 46(10), 1902-12.
- Bunch TJ, Asirvatham SJ, Friedman PA, Monahan KH, Munger TM, Rea RF, Sinak LJ, Packer DL (2005). Outcomes after cardiac perforation during radiofrequency ablation of the atrium. J Cardiovasc Electrophysiol, 16(11), 1172-9.
- Bunch TJ, White RD (2005). Trends in treated ventricular fibrillation in out-of-hospital cardiac arrest: ischemic compared to non-ischemic heart disease. Resuscitation, 67(1), 51-4.
- Mahapatra S, Bybee KA, Bunch TJ, Espinosa RE, Sinak LJ, McGoon MD, Hayes DL (2005). Incidence and predictors of cardiac perforation after permanent pacemaker placement. Heart Rhythm, 2(9), 907-11.
- Bruce GK, Bunch TJ, Milton MA, Sarabanda A, Johnson SB, Packer DL (2005). Discrepancies between catheter tip and tissue temperature in cooled-tip ablation: relevance to guiding left atrial ablation. Circulation, 112(7), 954-60.
- Jones HU, Muhlestein JB, Jones KW, Renlund DG, Bair TL, Bunch TJ, Horne BD, Lapp DL, Anderson JL, Doty DB (2003). Early postoperative use of unfractionated heparin or enoxaparin is associated with increased surgical re-exploration for bleeding. Ann Thorac Surg, 80(2), 518-22.
- Muhlestein JB, Anderson JL, Cui C, Lan Y, Bair TL, Bunch TJ, Pearson RR, Sorensen SG, Renlund DG, Zhang L, Horne BD, Vincent GM (2004). Improved long-term survival associated with stent deployment during percutaneous coronary interventions: results from a registry of 3399 patients. Am Heart J, 150(1), 182-7.
- White RD, Bunch TJ, Hankins DG (2004). Evolution of a community-wide early defibrillation programme experience over 13 years using police/fire personnel and paramedics as responders. Resuscitation, 65(3), 279-83.
- Bunch TJ, Hammill SC, White RD (2005). Outcomes after ventricular fibrillation out-of-hospital cardiac arrest: expanding the chain of survival. Mayo Clin Proc, 80(6), 774-82.
- Mahapatra S, Bunch TJ, White RD, Hodge DO, Packer DL (2004). Sex differences in outcome after ventricular fibrillation in out-of-hospital cardiac arrest. Resuscitation, 65(2), 197-202.
- Bunch TJ, Muhlestein JB, Bair TL, Renlund DG, Lapp DL, Jensen KR, Horne BD, Carter MA, Anderson JL, Intermountain Heart Collaborative Study Group (2004). Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure. Am J Cardiol, 95(7), 827-31.
- Bunch TJ, Bruce GK, Johnson SB, Sarabanda A, Milton MA, Packer DL (2004). Analysis of catheter-tip (8-mm) and actual tissue temperatures achieved during radiofrequency ablation at the orifice of the pulmonary vein. Circulation, 110(19), 2988-95.
- Muhlestein JB, Anderson JL, Horne BD, Carlquist JF, Bair TL, Bunch TJ, Pearson RR, Intermountain Heart Collaborative Study Group (2004). Early effects of statins in patients with coronary artery disease and high C-reactive protein. Am J Cardiol, 94(9), 1107-12.
- Bunch TJ, White RD, Bruce GK, Hammill SC, Gersh BJ, Shen WK, Carter MA, Packer DL (2004). Prediction of short- and long-term outcomes by electrocardiography in survivors of out-of-hospital cardiac arrest. Resuscitation, 63(2), 137-43.
- Bunch TJ, White RD, Friedman PA, Kottke TE, Wu LA, Packer DL (2004). Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: a 17-year population-based study. Heart Rhythm, 1(3), 255-9.
- Bunch TJ, White RD, Gersh BJ, Shen WK, Hammill SC, Packer DL (2004). Outcomes and in-hospital treatment of out-of-hospital cardiac arrest patients resuscitated from ventricular fibrillation by early defibrillation. Mayo Clin Proc, 79(5), 613-9.
- Khan AH, Bunch TJ, White RD, Packer DL (2003). Prognostic implication of early ejection fraction on long-term mortality and quality of life following out-of-hospital cardiac arrest. Am J Cardiol, 93(8), 1027-30.
- Bunch TJ, Chandrasekaran K, Gersh BJ, Hammill SC, Hodge DO, Khan AH, Packer DL, Pellikka PA (2003). The prognostic significance of exercise-induced atrial arrhythmias. J Am Coll Cardiol, 43(7), 1236-40.
- Bunch TJ, White RD, Khan AH, Packer DL (2004). Impact of age on long-term survival and quality of life following out-of-hospital cardiac arrest. Crit Care Med, 32(4), 963-7.
- Ghobrial IM, Bunch TJ, Caplice NM, Edwards WD, Miller DV, Litzow MR (2004). Fatal coronary artery disease after unrelated donor bone marrow transplantation. Mayo Clin Proc, 79(3), 403-6.
- Horne BD, Muhlestein JB, Lapp DL, Renlund DG, Bair TL, Bunch TJ, Anderson JL, Intermountain Heart Collaborative Study Group (2003). Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary disease. Ann Epidemiol, 14(2), 143-50.
- Bunch TJ, White RD, Smith GE, Hodge DO, Gersh BJ, Hammill SC, Shen WK, Packer DL (2003). Long-term subjective memory function in ventricular fibrillation out-of-hospital cardiac arrest survivors resuscitated by early defibrillation. Resuscitation, 60(2), 189-95.
- Horton SC, Bunch TJ (2004). Patent foramen ovale and stroke. Mayo Clin Proc, 79(1), 79-88.
- Bunch TJ, West CP, Packer DL, Panutich MS, White RD (2004). Admission predictors of in-hospital mortality and subsequent long-term outcome in survivors of ventricular fibrillation out-of-hospital cardiac arrest: a population-based study. Cardiology, 102(1), 41-7.
- Bunch TJ, Oh JK, Click RL (2003). Subepicardial aneurysm of the left ventricle. J Am Soc Echocardiogr, 16(12), 1318-21.
- Bunch TJ, Welsh GA, Miller DV, Santhi VS (2003). Case report: acute spontaneous Achilles tendon rupture in a patient with giant cell arteritis. Ann Clin Lab Sci, 33(3), 326-8.
- Bunch TJ, White RD, Gersh BJ, Meverden RA, Hodge DO, Ballman KV, Hammill SC, Shen WK, Packer DL (2003). Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. N Engl J Med, 348(26), 2626-33.
- Keelan PC, Bunch TJ, White RD, Packer DL, Holmes DR Jr (2003). Early direct coronary angioplasty in survivors of out-of-hospital cardiac arrest. Am J Cardiol, 91(12), 1461-3, A6.
- Jackson JD, Muhlestein JB, Bunch TJ, Bair TL, Horne BD, Madsen TE, Lapp JM, Anderson JL, Intermountain Heart Collaborative Study Group (2003). Beta-blockers reduce the incidence of clinical restenosis: prospective study of 4840 patients undergoing percutaneous coronary revascularization. Am Heart J, 145(5), 875-81.
- Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV, Russell SJ, Litzow MR, Edwards WD (2003). Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci U S A, 100(8), 4754-9.
- Bunch TJ, Thalji MK, Pellikka PA, Aksamit TR (2002). Respiratory failure in tetanus: case report and review of a 25-year experience. Chest, 122(4), 1488-92.
- Bunch TJ, Dunn WF, Basu A, Gosman RI (2003). Hyponatremia and hypoglycemia in acute Sheehan's syndrome. Gynecol Endocrinol, 16(5), 419-23.
- Bunch TJ, Birskovich LM, Eiken PW (2004). Diabetic myonecrosis in a previously healthy woman and review of a 25-year Mayo Clinic experience. Endocr Pract, 8(5), 343-6.
- Bunch TJ, Muhlestein JB, Anderson JL, Horne BD, Bair TL, Jackson JD, Li Q, Lapp DL (2002). Effects of statins on six-month survival and clinical restenosis frequency after coronary stent deployment. Am J Cardiol, 90(3), 299-302.
- Bunch TJ, Abraham D, Wang S, Meikle AW (2002). Pituitary radiographic abnormalities and clinical correlates of hypogonadism in elderly males presenting with erectile dysfunction. Aging Male, 5(1), 38-46.
- Muhlestein JB, Anderson JL, Carlquist JF, Salunkhe K, Horne BD, Pearson RR, Bunch TJ, Allen A, Trehan S, Nielson C (2000). Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation, 102(15), 1755-60.
- Ferreira PJ, Bunch TJ, Albertine KH, Carlton DP (2001). Circulating neutrophil concentration and respiratory distress in premature infants. J Pediatr, 136(4), 466-72.
- Wang S, Holyoak GR, Liu G, Bunch TJ, Evans RC, Bunch TD (1998). Effects of resazurin on bovine oocyte fertilization and embryo development in vitro. Anim Reprod Sci, 51(3), 205-13.
- Holyoak GR, Wang S, Liu G, Bunch TJ, Evans RC, Bunch TD (1998). The effects of ceftiofur sodium (Naxcel) on bovine oocyte and preimplantation embryonic development assessed by in vitro embryo production techniques. J Vet Pharmacol Ther, 21(2), 92-8.
Review
- Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, S Lim H, Lip GYH, Nava-Townsend S, Pak HN, Rodrguez Diez G, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Molano LFP, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C (2020). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. [Review]. J Arrhythm, 36(4), 553-607.
- Galenko O, Jacobs V, Bunch TJ (2019). Biomarkers in the risk assessment for stroke and dementia in atrial fibrillation. [Review]. Curr Opin Cardiol, 35(1), 1-7.
- Volgman AS, Bairey Merz CN, Aggarwal NT, Bittner V, Bunch TJ, Gorelick PB, Maki P, Patel HN, Poppas A, Ruskin J, Russo AM, Waldstein SR, Wenger NK, Yaffe K, Pepine CJ (2019). Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women? [Review]. J Am Heart Assoc, 8(19), e013154.
- Johnson DL, Day JD, Mahapatra S, Bunch TJ (2012). Adverse Outcomes from Atrial Fibrillation;Mechanisms, Risks, and Insights Learned from Therapeutic Options. [Review]. J Atr Fibrillation, 4(5), 477.
- Packer DL, Johnson SB, Kolasa MW, Bunch TJ, Henz BD, Okumura Y (2008). New generation of electro-anatomic mapping: full intracardiac ultrasound image integration. [Review]. Europace, 10 Suppl 3, iii35-41.
Conference Proceedings
Commentary
Case Report
- Melman YF, Steinberg BA, Lancaster J, Freedman RA, Bunch TJ, Cutler MJ (2021). Limitations of manufacturer-recommended remote monitoring in the St. Jude Assurity/Endurity battery recall. HeartRhythm Case Rep, 7(12), 791-794.
- Wang L, Catino A, Sheppard T, U Shah R, Bunch TJ, A Steinberg B (2020). Smartwatch Alert Mimicking Implantable Cardiac Defibrillator Alarm During Sleep. J Atr Fibrillation, 13(4), 2412.
- Sandhu A, Borne RT, Mam C, Bunch TJ, Aleong RG (2017). Double jeopardy: long QT3 and Brugada syndromes. Clin Case Rep, 5(8), 1315-1319.
Editorial
- Groh CA, Bunch TJ (2022). How to rebuild a damaged heart: The role of left bundle branch pacing to reduce functional mitral regurgitation. Heart Rhythm.
- Bunch TJ (2022). State of the Journal 2022: Heart Rhythm Case Reports. HeartRhythm Case Rep, 8(1), 1.
- Kwaku KF, Bunch TJ (2021). Which Patients Benefit Most From Primary Prevention ICDs?: A Call for More Nuanced Risk Stratification. JACC Clin Electrophysiol, 8(1), 12-14.
- Groh CA, Bunch TJ (2021). Early recurrence of atrial tachyarrhythmia post-atrial fibrillation ablation: Filling in the blank. Heart Rhythm, 18(9), 1471-1472.
- Bunch TJ (2021). Reflections from the Book of the Dead: Weighing the impact of epicardial fat on atrial fibrillation vulnerability. J Cardiovasc Electrophysiol, 32(4), 900-902.
- Bunch TJ (2021). State of the Journal 2021: Heart Rhythm Case Reports. HeartRhythm Case Rep, 7(1), 1-2.
- Bunch TJ (2020). Electrophysiology Coup d'Oeil: The Art of Papillary Muscle PVC Ablation. JACC Clin Electrophysiol, 6(11), 1393-1394.
- Bunch TJ, Steinberg BA (2020). Revisiting Rate versus Rhythm Control in Atrial Fibrillation - Timing Matters. N Engl J Med, 383(14), 1383-1384.
- Bunch TJ, Ranjan R (2019). Overestimation and Underweighting of Rare Events: The Challenge of Preventing Atrial-Esophageal Fistula After Ablation. JACC Clin Electrophysiol, 6(3), 269-271.
- Bunch TJ (2019). When it comes to the left atrial appendage, first do no harm. Heart Rhythm, 17(2), 182-183.
- Bunch TJ (2020). State of the Journal 2020: Heart Rhythm Case Reports. HeartRhythm Case Rep, 6(1), 1.
- Bunch TJ (2019). Who Will Benefit From an Implantable Cardioverter Defibrillator? Circ Cardiovasc Qual Outcomes, 12(8), e005995.
- Bunch TJ (2019). State of the Journal 2019: HeartRhythm Case Reports. HeartRhythm Case Rep, 5(1), 1.
- Bunch TJ (2018). Let go to grow: Reconciling your dependence on fluoroscopy for atrial fibrillation ablations. Pacing Clin Electrophysiol, 41(11), 1412-1413.
- Bunch TJ (2018). Mapping of atrial fibrillation: A test of faith. Heart Rhythm, 15(6), 888-889.
- Bunch TJ (2017). Excessive contact force can overcome irrigated tip catheter benefits during atrial fibrillation ablation. J Cardiovasc Electrophysiol, 29(2), 236-238.
- Bunch TJ (2018). State of the Journal 2018: HeartRhythm Case Reports. HeartRhythm Case Rep, 4(1), 1.
- Jared Bunch T (2017). State of the Journal 2017: HeartRhythm Case Reports. HeartRhythm Case Rep, 3(1), 1.
- Bunch TJ, Day JD (2017). Is left atrial appendage isolation a pyrrhic victory in the effort to treat atrial fibrillation? J Thorac Dis, 9(1), 1-4.
- Bunch TJ, May HT (2016). Atrial fibrillation: a risk factor or risk marker? Eur Heart J, 37(38), 2890-2892.
- Bunch TJ, Jacobs V (2016). Adverse brain aging in atrial fibrillation patients. Heart Rhythm, 13(10), 2025-6.
- Bunch TJ, Cutler MJ (2016). How Carbon Beams May Make Extracorporeal Ablation for Atrial Fibrillation a Reality. J Cardiovasc Electrophysiol, 27(3), 345-6.
- Jared Bunch T (2016). State of the journal 2016: HeartRhythm Case Reports. HeartRhythm Case Rep, 2(1), 1.
- Bunch TJ, Day JD (2015). Adverse Remodeling of the Left Atrium in Patients with Atrial Fibrillation: When Is the Tipping Point in Which Structural Changes Become Permanent? J Cardiovasc Electrophysiol, 26(6), 606-7.
- Bunch TJ, Day JD (2014). The electrophysiologist's new clothes and the cardiac MRI that told the truth. J Cardiovasc Electrophysiol, 25(5), 464-465.
- Bunch TJ, Day JD (2013). The atrial fibrillation ablation theory of relativity. J Cardiovasc Electrophysiol, 24(3), 267-8.
- Bunch TJ, Day JD (2012). Phrenic nerve pacing during atrial ablation: a stimulus plan that works. Pacing Clin Electrophysiol, 35(9), 1050-2.
- Bunch TJ, Day JD (2012). Examining the risks and benefits of transesophageal echocardiogram imaging during catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol, 5(4), 621-3.
- Bunch TJ, Mahapatra S (2012). Implications of continuous QT monitoring in the intensive care setting. Crit Care Med, 40(2), 658-9.
- Bunch TJ, Day JD (2011). Achieving favorable very long-term outcomes after catheter ablation for atrial fibrillation: an exciting adventure or delusional quest? J Cardiovasc Electrophysiol, 22(11), 1215-6.
- Bunch TJ, Day JD (2009). The significance of early atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a matter of time. J Cardiovasc Electrophysiol, 20(12), 1326-7.
- Bunch TJ, White RD (2009). Education is what remains after medical emergency teams are trained. Crit Care Med, 37(12), 3174-5.
- Hall N, Bunch TJ (2009). Defining new risk factors for out-of-hospital cardiac arrest: a hot opportunity for discovery. Crit Care Med, 37(12), 3178-9.
- Bunch TJ, Day JD (2009). Moving away from esophageal injury during left atrial ablation. Heart Rhythm, 6(3), 323-4.
- Bunch TJ, Day JD (2007). The diagnostic evolution of the cardiac implantable electronic device: the implantable monitor of ischemia. J Cardiovasc Electrophysiol, 19(3), 282-4.
- Bunch TJ, White RD (2008). A simplified approach to the challenging problem of resuscitation of patients who present in pulseless electrical activity. Crit Care Med, 36(2), 619-20.
- Bunch TJ, White RD (2007). Decision making with biomarkers after cardiac arrest: are we there yet? Crit Care Med, 35(5), 1411-2.
- Bunch TJ, Day JD (2007). Unraveling the mysteries of catheter ablation for atrial fibrillation: from clinical observations to mechanistic explorations. J Cardiovasc Electrophysiol, 18(3), 266-8.
- Bunch TJ, Day JD (2006). Right meets left: a common mechanism underlying right and left ventricular outflow tract tachycardias. J Cardiovasc Electrophysiol, 17(10), 1059-61.
- Bunch TJ, Ackerman MJ (2006). Promoting arrhythmia susceptibility. Circulation, 113(3), 330-2.
Letter
- Reddy VY, Exner DV, Doshi R, Tomassoni G, Bunch TJ, Estes NAM, Neuil P, Paulin FL, Garcia Guerrero JJ, Cantillon DJ, LEADLESS II Investigators (2021). Primary Results on Safety and Efficacy From the LEADLESS II-Phase 2 Worldwide Clinical Trial. [Letter to the editor]. JACC Clin Electrophysiol, 8, 115-117.
- Nielsen JC, Lin YJ, de Oliviera Figueiredo MJ, Shamloo AS, Bunch TJ (2020). EHRA/HRS/APHRS/LAHRS expert consensus on risk assessment in cardiac arrhythmias: Authors' reply. [Letter to the editor]. Europace, 23(4), 649.
- Muhlestein JB, Muhlestein JB, Anderson JL, Bethea CF, Severance HW, Mentz RJ, Barsness GW, Barbagelata A, Albert D, Le VT, Bunch TJ, Yanowitz F, May HT, Chisum B, Ronnow BS, Duke University Cooperative Cardiovascular Society DUCCS investigators (2020). Smartphone 12-lead ECG-Exciting but must be handled with care. [Letter to the editor]. Am Heart J, 226, 269.
- Anselmino M, Matta M, DAscenzo F, Bunch TJ, Schilling RJ, Hunter RJ, Pappone C, Neumann T, Noelker G, Fiala M, Bertaglia E, Frontera A, Duncan E, Nalliah C, Jais P, Weerasooriya R, Kalman JM, Gaita F (2015). Response to letter regarding "Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis". [Letter to the editor]. Circ Arrhythm Electrophysiol, 8(1), 246.
Other
- Chew DS, Li Z, Steinberg BA, OBrien EC, Pritchard J, Bunch TJ, Mark DB, Patel MR, Nabutovsky Y, Greiner MA, Piccini JP (2022). Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices. Circ Arrhythm Electrophysiol (15(2), pp. e010304). United States.
- Dar T, Turagam MK, Yarlagadda B, Parikh V, Pillarisetti J, Gopinathannair R, Gianni C, Mohanty S, Mansour M, Di Biase L, Bunch TJ, Natale A, Lakkireddy D (2020). Outcomes of junctional ectopic tachycardia ablation in adult population-a multicenter experience. J Interv Card Electrophysiol (61(1), pp. 19-27). Netherlands.
- Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, Lim HS, Lip GYH, Nava-Townsend S, Pak HN, Diez GR, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, ESC Scientific Document Group, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Pava Molano LF, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C (2020). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Heart Rhythm (17(9), pp. e269-e316). United States.
- Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, Lim HS, Lip GYH, Nava-Townsend S, Pak HN, Rodrguez Diez G, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, ESC Scientific Document Group, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Pava Molano LF, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C (2020). European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Europace (22(8), pp. 1147-1148). England.
- Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Mallender C, Weiss JP, Osborn JS, Day JD (2019). Long-term outcomes after low power, slower movement versus high power, faster movement irrigated-tip catheter ablation for atrial fibrillation. Heart Rhythm (17(2), pp. 184-189). United States.
- Natale A, Mohanty S, Liu PY, Mittal S, Al-Ahmad A, De Lurgio DB, Horton R, Spear W, Bailey S, Bunch J, Musat D, ONeill P, Compton S, Turakhia MP, AMBULATE Trial Investigators (2019). Venous Vascular Closure System Versus Manual Compression Following Multiple Access Electrophysiology Procedures: The AMBULATE Trial. JACC Clin Electrophysiol (6(1), pp. 111-124). United States.
- Regouski M, Galenko O, Doleac J, Olsen AL, Jacobs V, Liechty D, White KL, Bunch TJ, Lee PM, Rutigliano HM, Polejaeva IA, Cutler MJ (2019). Spontaneous Atrial Fibrillation in Transgenic Goats With TGF (Transforming Growth Factor)-β1 Induced Atrial Myopathy With Endurance Exercise. Circ Arrhythm Electrophysiol (12(11), pp. e007499). United States.
- Ng R, Manring H, Papoutsidakis N, Albertelli T, Tsai N, See CJ, Li X, Park J, Stevens TL, Bobbili PJ, Riaz M, Ren Y, Stoddard CE, Janssen PM, Bunch TJ, Hall SP, Lo YC, Jacoby DL, Qyang Y, Wright N, Ackermann MA, Campbell SG (2019). Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation. JCI Insight (5). United States.
Patent
- Bunch TJ (2018). Defibrillators with multi-pad electrodes and related methods. U.S. Patent No. 1,000,489,4B2. Washington, D.C.:U.S. Patent and Trademark Office.
- Bunch TJ, Orr TJ, Stevens B (2017). Devices for creation of multiple vascular access sites. U.S. Patent No. 971,369,5B2. Washington, D.C.:U.S. Patent and Trademark Office.
- Bunch TJ, Day JD (2016). Atrial fibrillation treatment systems and methods. U.S. Patent No. 929,539,9B2. Washington, D.C.:U.S. Patent and Trademark Office.
- Bunch TJ, Orr TJ (2015). Fluidic esophageal heat sensors. U.S. Patent No. 9,044,142 B2. Washington, D.C.:U.S. Patent and Trademark Office.
- Doty JR, Bunch TJ, Orr TJ (2014). Magnetically coupling devices for mapping and/or ablations. U.S. Patent No. 8,641,710 B2. Washington, D.C.:U.S. Patent and Trademark Office.